Combination treatment of dipeptidyl peptidase IV inhibitor and angiotensin-II type 1 receptor blocker attenuates progression of nonalcoholic steatohepatitis in rats

被引：0
|
作者：
Okura, Yasushi [1 ]
Namisaki, Tadashi [1 ]
Kaji, Kosuke [1 ]
Noguchi, Ryuichi [1 ]
Takeda, Kosuke [1 ]
Moriya, Kei [1 ]
Kitade, Mitsuteru [1 ]
Nishimura, Norihisa [1 ]
Seki, Kenichiro [1 ]
Sato, Shinya [1 ]
Takaya, Hiroaki [1 ]
Kawaratani, Hideto [1 ]
Sawada, Yasuhiko [1 ]
Shimozato, Naotaka [1 ]
Nakanishi, Keisuke [1 ]
Yoshiji, Hitoshi [1 ]
机构：
[1] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1610
引用
收藏
页码：798A / 798A
页数：1
相关论文
共 50 条
  • [21] ANGIOTENSIN-II RECEPTOR BLOCKER BUT NOT ACE INHIBITOR ATTENUATES THE HYPERTROPHIC RESPONSE OF THE HEART TO CARDIAC VOLUME OVERLOAD IN RATS
    RUZICKA, M
    LEENEN, FHH
    HYPERTENSION, 1993, 21 (04) : 539 - 539
  • [22] Combined treatment with a dipeptidyl peptidase-IV inhibitor (sitagliptin) and an angiotensin II type 1 receptor blocker (losartan) promotes islet regeneration via enhanced differentiation of pancreatic progenitor cells
    Liang, J.
    Leung, K. K.
    Lam, S. Y.
    Leung, P. S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 842 - 851
  • [23] Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
    Tamaki, Yosui
    Nakade, Yukiomi
    Yamauchi, Taeko
    Makino, Yuichi
    Yokohama, Shiro
    Okada, Mitsuyoshi
    Aso, Kazunobu
    Kanamori, Hiroyuki
    Ohashi, Tomohiko
    Sato, Ken
    Nakao, Haruhisa
    Haneda, Masakazu
    Yoneda, Masashi
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (04) : 491 - 503
  • [24] Angiotensin II type 1 receptor antagonist prevents hepatic carcinoma in rats with nonalcoholic steatohepatitis
    Yosui Tamaki
    Yukiomi Nakade
    Taeko Yamauchi
    Yuichi Makino
    Shiro Yokohama
    Mitsuyoshi Okada
    Kazunobu Aso
    Hiroyuki Kanamori
    Tomohiko Ohashi
    Ken Sato
    Haruhisa Nakao
    Masakazu Haneda
    Masashi Yoneda
    Journal of Gastroenterology, 2013, 48 : 491 - 503
  • [25] Cocktail therapy with a combination of interferon, ribavirin and angiotensin-II type 1 receptor blocker attenuates murine Liver fibrosis development
    Yoshiji, Hitoshi
    Noguchi, Ryuichi
    Ikenaka, Yasuhide
    Kaji, Kosuke
    Aihara, Yosuke
    Shirai, Yusaku
    Yoshii, Junichi
    Yanase, Koji
    Fukui, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2011, 28 (01) : 81 - 88
  • [26] The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
    Javad Habibi
    Annayya R. Aroor
    Nitin A. Das
    Camila M. Manrique-Acevedo
    Megan S. Johnson
    Melvin R. Hayden
    Ravi Nistala
    Charles Wiedmeyer
    Bysani Chandrasekar
    Vincent G. DeMarco
    Cardiovascular Diabetology, 18
  • [27] The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
    Habibi, Javad
    Aroor, Annayya R.
    Das, Nitin A.
    Manrique-Acevedo, Camila M.
    Johnson, Megan S.
    Hayden, Melvin R.
    Nistala, Ravi
    Wiedmeyer, Charles
    Chandrasekar, Bysani
    DeMarco, Vincent G.
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [28] The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy
    Tsuprykov, Oleg
    Ando, Ryotaro
    Reichetzeder, Christoph
    von Websky, Karoline
    Antonenko, Viktoriia
    Sharkovska, Yuliya
    Chaykovska, Lyubov
    Rahnenfuehrer, Jan
    Hasan, Ahmed A.
    Tammen, Harald
    Alter, Markus
    Klein, Thomas
    Ueda, Seiji
    Yamagishi, Sho-ichi
    Okuda, Seiya
    Hocher, Berthold
    KIDNEY INTERNATIONAL, 2016, 89 (05) : 1049 - 1061
  • [29] COMBINATION OF SELECTIVE NOTCH1 INHIBITOR WITH ANGIOTENSIN-II RECEPTOR BLOCKER SUPPRESSES ORTHOTOPIC CHOLANGIOCARCINOMA GROWTH
    Saikawa, Soichiro
    Kaji, Kosuke
    Tsuji, Yuki
    Nakanishi, Keisuke
    Sato, Shinya
    Kawaratani, Hideto
    Namisaki, Tadashi
    Yoshiji, Hitoshi
    HEPATOLOGY, 2019, 70 : 1118A - 1118A
  • [30] Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report
    Skalli, S.
    Wion-Barbot, N.
    Baudrant, M.
    Lablanche, S.
    Benhamou, P. Y.
    Halimi, S.
    DIABETIC MEDICINE, 2010, 27 (04) : 486 - 487
12345